Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Halloran

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Statistics in Medicine|March 4, 1998
Augmented HIV vaccine trial design for estimating reduction in infectiousness and protective efficacyS Datta, M E Halloran, I M Longini
Biometrics|April 21, 2001
Efficiency of estimating vaccine efficacy for susceptibility and infectiousness: randomization by individual versus householdS Datta, M E Halloran, I M Longini
American Journal of Epidemiology|August 11, 1992
Interpretation and estimation of vaccine efficacy under heterogeneityM E Halloran, M Haber, I M Longini
American Journal of Epidemiology|July 1, 1996
Estimability and interpretation of vaccine efficacy using frailty mixing modelsM E Halloran, I M Longini, C J Struchiner
Statistics in Medicine|November 20, 1998
Semi-parametric models for mismeasured exposure information in vaccine trialsG T Golm, M E Halloran, I M Longini
Epidemiology (Cambridge, Mass.)|November 1, 1994
Empirical Bayes methods for stabilizing incidence rates before mappingO J Devine, T A Louis, M E Halloran
Mathematical Biosciences|July 1, 1993
On the distribution of vaccine protection under heterogeneous responseR C Brunet, C J Struchiner, M E Halloran
International Journal of Epidemiology|August 1, 1997
A case-control study of the effectiveness of BCG vaccine for preventing leprosy in Yangon, MyanmarJ Bertolli, C Pangi, R Frerichs, et al.
American Journal of Epidemiology|December 31, 1997
Study designs for evaluating different efficacy and effectiveness aspects of vaccinesM E Halloran, C J Struchiner, I M Longini
Epidemiologic Reviews|October 16, 1999
Design and interpretation of vaccine field studiesM E Halloran, I M Longini, C J Struchiner
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Statistics in Medicine|March 4, 1998
Augmented HIV vaccine trial design for estimating reduction in infectiousness and protective efficacyS Datta, M E Halloran, I M Longini
Biometrics|April 21, 2001
Efficiency of estimating vaccine efficacy for susceptibility and infectiousness: randomization by individual versus householdS Datta, M E Halloran, I M Longini
American Journal of Epidemiology|August 11, 1992
Interpretation and estimation of vaccine efficacy under heterogeneityM E Halloran, M Haber, I M Longini
American Journal of Epidemiology|July 1, 1996
Estimability and interpretation of vaccine efficacy using frailty mixing modelsM E Halloran, I M Longini, C J Struchiner
Statistics in Medicine|November 20, 1998
Semi-parametric models for mismeasured exposure information in vaccine trialsG T Golm, M E Halloran, I M Longini
Epidemiology (Cambridge, Mass.)|November 1, 1994
Empirical Bayes methods for stabilizing incidence rates before mappingO J Devine, T A Louis, M E Halloran
Mathematical Biosciences|July 1, 1993
On the distribution of vaccine protection under heterogeneous responseR C Brunet, C J Struchiner, M E Halloran
International Journal of Epidemiology|August 1, 1997
A case-control study of the effectiveness of BCG vaccine for preventing leprosy in Yangon, MyanmarJ Bertolli, C Pangi, R Frerichs, et al.
American Journal of Epidemiology|December 31, 1997
Study designs for evaluating different efficacy and effectiveness aspects of vaccinesM E Halloran, C J Struchiner, I M Longini
Epidemiologic Reviews|October 16, 1999
Design and interpretation of vaccine field studiesM E Halloran, I M Longini, C J Struchiner
Pageof 8